Studies on the association between clinical severity scores for pneumonia, such as CURB65 and PSI, with biomarkers like CRP (C-reactive protein), procalcitonin (PCT), and suPAR (soluble urokinase plasminogen activator receptor) show varied results. This evidence concerns the gene CRP and susceptibility to pneumonia measurement.